Literature DB >> 15003933

The LAM cell: what is it, where does it come from, and why does it grow?

G Finlay.   

Abstract

Mesh：

Year:  2004        PMID： 15003933     DOI： 10.1152/ajplung.00311.2003

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN： 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  16 in total

1.  Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.

Authors:  Arnold S Kristof; Zhipeng You; Yin-Shan Han; Adel Giaid
Journal:  Peptides       Date:  2010-04-28       Impact factor: 3.750

2.  Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.

Authors:  Elena A Goncharova; Dmitriy A Goncharov; Poay N Lim; Daniel Noonan; Vera P Krymskaya
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-30       Impact factor: 6.914

3.  Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

Authors:  Lisa M Julian; Sean P Delaney; Ying Wang; Alexander A Goldberg; Carole Doré; Julien Yockell-Lelièvre; Roger Y Tam; Krinio Giannikou; Fiona McMurray; Molly S Shoichet; Mary-Ellen Harper; Elizabeth P Henske; David J Kwiatkowski; Thomas N Darling; Joel Moss; Arnold S Kristof; William L Stanford
Journal:  Cancer Res       Date:  2017-08-22       Impact factor: 12.701

4.  Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.

Authors:  Elizabeth A Barnes; Heidi L Kenerson; Xiuyun Jiang; Raymond S Yeung
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

Review 5.  Lymphangioleiomyomatosis: what do we know and what are we looking for?

Authors:  S Harari; O Torre; J Moss
Journal:  Eur Respir Rev       Date:  2011-03

6.  Lymphangioleiomyoma cells and lymphatic endothelial cells: expression of VEGFR-3 in lymphangioleiomyoma cell clusters.

Authors:  Kuniaki Seyama; Keiko Mitani; Toshio Kumasaka; Shiv K Gupta; Saji Oommen; Gang Liu; Jay H Ryu; Nicholas E Vlahakis
Journal:  Am J Pathol       Date:  2010-03-04       Impact factor: 4.307

7.  Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.

Authors:  J Kenneth Schoolmeester; Kay J Park
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

8.  Metabolic Impact of Rapamycin (Sirolimus) and B-Estradiol Using Mouse Embryonic Fibroblasts as a Model for Lymphangioleiomyomatosis.

Authors:  Katherine M Marsh; David Schipper; Alice S Ferng; Kitsie Johnson; Julia Fisher; Shannon Knapp; Destiny Dicken; Zain Khalpey
Journal:  Lung       Date:  2017-06-02       Impact factor: 2.584

9.  Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.

Authors:  Rachel B Issaka; Saji Oommen; Shiv K Gupta; Gang Liu; Jeffrey L Myers; Jay H Ryu; Nicholas E Vlahakis
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

Review 10.  Lymphangioleiomyomatosis and tuberous sclerosis complex.

Authors:  Dimitrios Chorianopoulos; Grigoris Stratakos
Journal:  Lung       Date:  2008-04-12       Impact factor: 2.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.